Managing acute and chronic renal stone disease

Area of Science:

• Nephrology
• Urology
• Radiology

Background:

• Nephrolithiasis (kidney stones) is a common condition with increasing global incidence.
• Factors contributing to increased stone incidence include rising obesity rates and Western dietary patterns high in animal protein and salt.
• The lifetime risk of kidney stones in the UK is estimated at 8-10%.

Purpose of the Study:

• To outline current diagnostic imaging techniques for nephrolithiasis.
• To provide guidance on pain management strategies for kidney stones.
• To establish criteria for intervention versus conservative management based on stone size.

Main Methods:

• Review of diagnostic imaging modalities for kidney stones, emphasizing non-contrast CT of the kidneys, ureters, and bladder (CT KUB) as the gold standard.
• Discussion of alternative imaging such as ultrasound KUB and plain film KUB for follow-up.
• Evaluation of analgesic options including NSAIDs (diclofenac), opioids, and combination therapies.

Main Results:

• Non-contrast CT KUB offers >99% sensitivity for stone detection and is the primary imaging choice.
• Ultrasound KUB is a radiation-free, cost-effective alternative but has lower sensitivity, especially for ureteric stones.
• Diclofenac is a recommended first-line analgesic; opioid use is reserved for NSAID contraindications. Management strategies vary by stone size, with stones <5 mm expected to pass spontaneously.

Conclusions:

• CT KUB is the definitive diagnostic tool for nephrolithiasis.
• Effective pain management is crucial, with NSAIDs often preferred.
• Stone size dictates management, with larger stones (>10 mm) or those between 5-10 mm often requiring urological intervention.